Dyadic International (NASDAQ:DYAI) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened

Dyadic International, Inc. (NASDAQ:DYAI)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $1.48 and traded as high as $1.93. Dyadic International shares last traded at $1.75, with a volume of 265,677 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 price objective on shares of Dyadic International in a research report on Thursday, November 14th.

Dyadic International Stock Performance

The company has a market cap of $54.44 million, a PE ratio of -8.00 and a beta of 0.89. The company has a current ratio of 5.15, a quick ratio of 5.15 and a debt-to-equity ratio of 1.54. The business’s 50 day moving average is $1.49 and its two-hundred day moving average is $1.39.

Dyadic International (NASDAQ:DYAI) last released its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.06. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. The firm had revenue of $1.96 million during the quarter, compared to analysts’ expectations of $1.05 million. During the same quarter last year, the business posted ($0.06) earnings per share. On average, equities research analysts anticipate that Dyadic International, Inc. will post -0.18 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Dyadic International stock. Chapin Davis Inc. raised its stake in Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 868,301 shares of the biotechnology company’s stock after buying an additional 21,000 shares during the period. Chapin Davis Inc. owned about 2.97% of Dyadic International worth $903,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 27.95% of the stock is currently owned by institutional investors and hedge funds.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.